Meet the editor

Sonia Maciá, MD, is an ESMO-certified Medical Oncologist. She obtained a master's degree in Pharmacoeconomy in 2018 from Universitat Pompeu Fabra Barcelona and a PhD in Lung Cancer from the Department of Clinical Medicine, University Miguel Hernández. Dr. Maciá worked as a practicing Medical Oncologist for nine years and then decided to devote her career to clinical research. In 2012 she joined Pivotal SL, a European CRO, as

Medical Manager, being thereafter promoted to Medical Director. After a few months in a similar role at ICON Plc, she joined Highlight Therapeutics to work on clinical development, providing medical support to clinical trials in solid tumors. Dr. Maciá has submitted more than forty abstracts to international congresses, published more than thirty papers in peer-reviewed journals, and authored six book chapters.

Contents

**Section 1**

*by Sonia Maciá*

*and Cosmin Vasile Obleaga*

*and Vita Dolžan*

*and Viji Shridhar*

in Mesothelioma

**Section 3**

**Section 4**

**Section 2**

**Preface XI**

Introduction **1**

**Chapter 1 3**

Clinical and Therapeutics **15**

**Chapter 2 17**

**Chapter 3 31**

Emerging Drugs **43**

**Chapter 4 45**

Predictive and Prognostic Biomarkers **59**

**Chapter 5 61**

*by Rodríguez-Cid Jeronimo Rafael and Flores-Mariñelarena Rodrigo Rafael*

Mesothelioma, a Review of Current Guidelines

Peritoneal Mesothelioma: Clinical and Therapeutic Aspects *by Cristian Mesina, Mihaela-Iustina Mesina-Botoran, Theodor Viorel Dumitrescu, Mihai Calin Ciorbagiu* 

Current Mesothelioma Treatment and Future Perspectives

*by Danijela Štrbac, Katja Goričar, Viljem Kovač*

Emerging Drug Therapies for Mesothelioma *by Derek B. Oien, Jeremy Chien, Julian Molina* 

Predictive and Prognosis Factors of Clinical Utility
